Organon & Co (NYSE: OGN) is 12.14% higher on its value in year-to-date trading and has touched a low of $10.84 and a high of $23.10 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The OGN stock was last observed hovering at around $15.28 in the last trading session, with the day’s gains setting it 0.89%.
Currently trading at $16.17, the stock is 0.33% and -7.68% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.57 million and changing 5.82% at the moment leaves the stock -16.05% off its SMA200. OGN registered 42.34% gain for a year compared to 6-month loss of -22.93%. The firm has a 50-day simple moving average (SMA 50) of $17.6102 and a 200-day simple moving average (SMA200) of $19.26205.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.77% gain in the last 1 month and extending the period to 3 months gives it a -27.84%, and is 7.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.58% over the week and 3.79% over the month.
Organon & Co (OGN) has around 10000 employees, a market worth around $4.16B and $6.41B in sales. Current P/E ratio is 3.21 and Fwd P/E is 3.82. Profit margin for the company is 20.30%. Distance from 52-week low is 49.24% and -30.00% from its 52-week high. The company has generated returns on investments over the last 12 months (14.09%).
with sales reaching $1.59B over the same period.The EPS is expected to shrink by -0.39% this year, but quarterly earnings will post 2.16% year-over-year. Quarterly sales are estimated to shrink -0.44% in year-over-year returns.
Organon & Co (OGN) Top Institutional Holders
923.0 institutions hold shares in Organon & Co (OGN), with institutional investors hold 81.81% of the company’s shares. The shares outstanding are 257.54M, and float is at 256.97M with Short Float at 5.51%. Institutions hold 81.67% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 32.58 million shares valued at $674.39 million. The investor’s holdings represent 12.7414% of the OGN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 30.21 million shares valued at $625.41 million to account for 11.8161 of the shares outstanding. The other top investors are MASSACHUSETTS FINANCIAL SERVICES CO /MA/ which holds 10.09 million shares representing 3.9465% and valued at over $208.88 million, while STATE STREET CORP holds 3.5234 of the shares totaling 9.01 million with a market value of $186.49 million.
Organon & Co (OGN) Insider Activity
The most recent transaction is an insider purchase by Weaver Kirke, the company’s Gen. Counsel & Corp. Secy. SEC filings show that Weaver Kirke bought 2,720 shares of the company’s common stock on Feb 22 ’24 at a price of $18.36 per share for a total of $49939.0. Following the purchase, the insider now owns 15181.0 shares.
